RUNX2 and chronic kidney disease: Besides, Spir could also alleviate apoptosis, reduce the expression of α-SMA (myofibroblast marker), CCR2(inflammatory response marker), and increase Runx2 (an early indicator of cellular calcification), thereby improving vascular calcification of CKD.